ALNICHE LIFE SCIENCES PVT LTD

New Delhi-based Alniche Life Sciences generated a revenue figure of Rs 38 crore in the biopharma space during FY 20-21, maintaining a steady phase in comparison to the revenue generation of Rs 37 crore in the previous year. A key development for Alniche during FY 20-21 was when it ventured into manufacturing in its state-of-the-art facility under the name of EffiKasia Lifesciences at Kangra, Himachal Pradesh. EffiKasia Lifesciences will manufacture pharmaceuticals, nutraceuticals and dermatologicals. In the future, the company plans to expand its manufacturing capacities to contract-manufacturing for others, thus making its mark in the CMO space.